(Q38019859)

27 August 2017

title

Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis (English)

1 reference

27 August 2017

0 references

4

Rhonda L Bohn

1 reference

27 August 2017

Patricia Tennis

1

1 reference

27 August 2017

Kenneth J Rothman

2

1 reference

27 August 2017

Kenneth J Rothman

3

1 reference

27 August 2017

Hiangkiat Tan

5

1 reference

27 August 2017

Athanasios Zavras

6

1 reference

27 August 2017

Constantinos Laskarides

7

1 reference

27 August 2017

Brian Calingaert

8

1 reference

27 August 2017

Mary S Anthony

9

1 reference

27 August 2017

publication date

19 June 2012

1 reference

Pharmacoepidemiology and Drug Safety

27 August 2017

published in

1 reference

27 August 2017

volume

21

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

810-817

1 reference

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update

27 August 2017

cites work

1 reference

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

21 January 2018

1 reference

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

21 January 2018

1 reference

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

21 January 2018

1 reference

Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people

21 January 2018

1 reference

Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?

21 January 2018

1 reference

Long-term use of bisphosphonates in osteoporosis

21 January 2018

1 reference

Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.

21 January 2018

1 reference

Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy

21 January 2018

1 reference

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

21 January 2018

1 reference

The impact of bisphosphonates on oral health: lessons from the past and opportunities for the future

21 January 2018

1 reference

The effect of intravenous pamidronate versus oral alendronate on bone mineral density in patients with osteoporosis.

21 January 2018

1 reference

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.3292

1 reference

27 August 2017

1 reference